KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Profit After Tax (2016 - 2025)

AbbVie (ABBV) has disclosed Profit After Tax for 14 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 8354.55% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 billion through Dec 2025, down 1.22% year-over-year, with the annual reading at $4.2 billion for FY2025, 1.05% down from the prior year.
  • Profit After Tax for Q4 2025 was $1.8 billion at AbbVie, up from $186.0 million in the prior quarter.
  • The five-year high for Profit After Tax was $4.5 billion in Q1 2022, with the low at -$22.0 million in Q4 2024.
  • Average Profit After Tax over 5 years is $1.8 billion, with a median of $1.5 billion recorded in 2024.
  • The sharpest move saw Profit After Tax surged 11133.33% in 2021, then crashed 102.68% in 2024.
  • Over 5 years, Profit After Tax stood at $4.0 billion in 2021, then tumbled by 38.85% to $2.5 billion in 2022, then crashed by 66.76% to $822.0 million in 2023, then crashed by 102.68% to -$22.0 million in 2024, then surged by 8354.55% to $1.8 billion in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at $1.8 billion, $186.0 million, and $938.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.